Combined Blood Stem Cell and Kidney Transplant of One Haplotype Match Living Donor Pairs.
Status:
Recruiting
Trial end date:
2024-06-14
Target enrollment:
Participant gender:
Summary
The Stanford Medical Center Program in Multi-Organ Transplantation and the Division of Bone
marrow Transplantation are enrolling patients into a research study to determine if donor
stem cells given after a living related one Haplotype match kidney transplantation will
change the immune system such that immunosuppressive drugs can be completely withdrawn.